服務

Medebound HEALTH提供全方位的虛擬護理解決方案,包括專家醫療意見,企業支持,按需全球護理,旨在為人們提供答案和結果,無論他們身何處或身體狀況如何。

Science Lab

對於雇主

我們已經制定了員工福利計劃。這利用了我們世界一流的獨立醫師小組提供的在線第二意見,以幫助企業改善員工的護理,同時通過鼓勵參與者獲得第二意見來降低健康保險費的成本。

對於患者

當面臨嚴重或威脅生命的醫學診斷時,Medebound HEALTH使其成員能夠對健康和治療計劃做出更自信,更明智的決定。

Pharmacist

FAQs

What is a Named Patient program?


A Named Patient Program provides access to post-approval drugs that are approved and commercially available in one country other than patient's home country. The program enables healthcare professionals across the world to access new medicines, for patients who have no other treatment options available to them in their own countries,through a process known as the Personal Importation Process.




What are the advantages for companies of conducting a Named Patient program?


There are many advantages for biopharma companies with a newly approved medicine: - Managing unsolicited patient requests for drugs in an ethical and regulatory controlled manner - Building a stronger network of KOLs and future advocates by exposing physicians in new markets to your products - Providing benefits to patients suffering from conditions, including some that can be life-threatening. - Generating additional revenues in countries that allow you to charge for drugs supplied on a named patient basis




Can pharmaceutical companies provide drug to patients in any country?


Companies can provide drugs to patients in any country in which they have not yet received marketing authorization. This includes countries in which a company plans to seek marketing approval, as well as those countries in which a company does not plan to seek marketing approval. With a properly established Named Patient program, we help navigate the complex regulatory landscape, especially in Asia countries, and manage the shipment, customs clearance, and delivery to treating clinics.




How can I introduce Medebound HEALTH to a biopharma company?


We can share introduction materials or schedule a demo to learn more about our full range of offerings.




Why choose Medebound HEALTH to be your partner in Asia?


With access to our in-house expertise and knowledge of international regulatory and legal frameworks in Asia, we will be able to help pharmaceutical companies gain market access which will not only generate early revenue for them but also provide them with real-world evidence (RWE) crucial to local regulatory approval. In addition to helping your products reach key Asian markets, where we have significant network and in-depth industry and regulatory knowledge, we have developed a AI enabled proprietary software to conduct Real World Evidence (RWE) for a select segment of the population. Having this data will give you a regulatory advantage if you decide to obtain market approval for this population.